Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

DDD > clinical trials > Flashcards

clinical trials Flashcards

(78 cards)

Start Studying
1
Q

It is a systematic process that is intended to find out the safety and
efficacy of a drug/device in treating/preventing/diagnosing a disease or a medical condition.

A

Clinical Trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

It involves the study of the effect of an investigational drug/any other intervention in a defined population/participant.

A

Clinical Trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

These are exploratory trial phases

A

Phase 0
Phase II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

It is termed as the non-therapeutic phase

A

Phase I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

It is known as the therapeutic confirmatory phase

A

Phase III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

It is called the post-approval or the post-marketing surveillance phase

A

Phase IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Study participants are randomly assigned to a group

A

Randomized Trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A type of CT where both study subjects and the researchers are aware of the drug being tested.

A

Open-label Clinical Trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In this type of CT, the subject has no idea about the group (test/control) in which they are placed

A

Single-Blind Clinical Trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In this CT, the subjects as well as the investigator have no idea about the test/control group.

A

Double-Blind Clinical Trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A substance that appears like a drug but has no active moiety

A

Placebo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

An additional drug apart from the clinical trial drug given to a group of study participants

A

Add-On

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A study being carried out at a particular place/location/center

A

Single-Center

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A study is being carried out at multiple places/locations/centers

A

Multi-Center

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical trials are broadly classified into:

A

Controlled and Uncontrolled Trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

These are potentially biased, and the results of such research are not
considered as equally as the controlled studies.

A

Uncontrolled Trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

These are considered the most effective clinical trials wherein the bias is minimized, and the results are considered reliable.

A

Randomized controlled trials (RCTs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The participants are assigned to a case or a control group based on flipping coin results/computer assignment.

A

Simple Randomization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Equal and small groups of both cases and controls

A

Block Randomization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Randomization based on the age of the participant and other covariates

A

Stratified Randomization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Sequential assignment of a new participant into a group based on the covariates

A

Co-Variate Adaptive Randomization/Minimization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

One intervention is administered to one-half of the body and the comparator intervention is assigned to another half of the body.

A

Randomization by Body Halves or Paired Organs (Split Body Trials)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Intervention is administered to clusters/groups by randomization to prevent contamination and either active or comparator intervention is administered for each group.

A

Clustered Randomization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Patients are allocated to one of the two trial arms

A

Allocation by Randomized Consent (Zelen Trials)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Clinical research design has two major types that include:
Non-Interventional / Observational Interventional / Experimental
26
The non-interventional studies may have a comparator group (analytical studies like case-control and cohort studies), or without it (descriptive study). The experimental studies may be either randomized or non-randomized.
27
This is the most frequent design wherein each arm of the study group is allocated a particular treatment (placebo (an inert substance)/therapeutic drug)
Parallel
28
The patient in this trial gets each drug and the patients serve as a control themselves. It has a washout period.
Crossover
29
Two or more interventions on the participants and the study can provide information on the interactions between the drugs
Factorial
30
This study evaluates the time/duration of the drug therapy - It uses a placebo to understand the efficacy of a drug in treating the disease
Randomized Withdrawal Approach
31
Recruit patients with the same characteristics. • Less Variability
Matched Pairs
32
It is the most frequently performed clinical research. This type of research is undertaken to analyze the presence or absence of a disease/condition, potential risk factors, and prevalence and incidence rates in a defined population.
Cross-Sectional Study Design
33
Clinical trials may be _____ type depending on the type of intervention
therapeutic or non-therapeutic
34
This type of clinical trial uses a drug that may be beneficial to the patient.
therapeutic
35
In this type of clinical trial, the participant does not benefit from the drug. It provide additional knowledge of the drug for future improvements.
non-therapeutic
36
The clinical trial process involves:
• Protocol Development • Designing a Case Record/Report Form • Functioning of Institutional Review Boards • Data Management • Monitoring Clinical Trial Site Activities
37
It is the most significant document in a clinical study. It contains the information collected by the investigator about each subject participating in a clinical study/trial.
Case Record/Report Form (CRF)
38
The clinical study is conducted by a:
sponsor or a clinical research organization (CRO)
39
NOTE: The two most important points to consider before the initiation of the clinical trial include whether there is a need for a clinical trial, if there is a need, then one must make sure that the study design and methodology are strong for the results to be reliable to the people.
40
Examines too low (1/100th) concentrations (micro-dosing) of the drug for less time. Study the pharmacokinetics and determine the dose for phase I studies.
Phase 0
41
• Around less than 50 healthy subjects are recruited. • Establishes a safe dose range, and the MTD. • Examines the pharmacokinetic and pharmacodynamic effects. • Usually single-center studies.
Phase I
42
Phase IA
Focus: Single Ascending Dose (SAD) and Maximum Tolerated Dose (MTD) Duration: 1 week to several months Includes: 6-8 groups of 3-6 participants
43
Phase IIB
Focus: Multiple Ascending Doses (MAD) and the dose is gradually narrowed down. Includes: Three groups of 8 individuals each.
44
• Around 5-100 patients of either sex. • Examines the effective dosage and the therapeutic effects on patients. • It decides the therapeutic regimen and drug-drug interactions. • Usually, multicentre studies.
Phase II
45
Decides the drug dosage, includes 20-30 patients, and takes up to weeks/months.
Phase IIA
46
Studies dose-response relationship, drug-drug interactions, and comparison with a placebo.
Phase IIB
47
• More than 300 patients (up to 3000) of either sex are recruited in this study and are multicentric trials. • Pre marketing phase examines the efficacy and the safety of the drug.
Phase III
48
• Comparison of the test drug with the placebo/standard drug. • Adverse drug reactions/adverse events are noted. • Initiate the process of NDA with appropriate regulatory agencies like the FDA.
Phase III
49
• After approval/post-licensure and post- marketing studies/surveillance studies. • Following up on the patients for an exceptionally long time for potential adverse reactions and drug-drug interactions.
Phase IV
50
Phase I CT
• Dose Escalation (SAD) • Safety Monitoring • Maximum Tolerated Dose (MTD)
51
Phase II CT
• Efficacy Evaluation • Safety Profile • Dose Optimization
52
Study Design and Methodology
• Protocol Development • Randomization • Blinding
53
Specific disease characteristics, age range, and health status for eligibility.
Inclusion Criteria
54
Conditions or factors that could interfere with the study or patient safety.
Exclusion Criteria
55
Outreach through healthcare providers, patient advocacy groups, and targeted advertising.
Recruitment Strategies
56
Main outcome measure, such as tumor size reduction or symptom improvement.
Primary Endpoint
57
Biological indicators used to track treatment response and disease progression.
Biomarkers
58
Additional measures to support primary endpoint and gather more data.
Secondary Endpoints
59
Patient-reported outcomes to assess overall well-being and treatment impact.
Quality of Life
60
Systematic documentation of any unexpected medical occurrences during the trial.
Adverse Event Reporting
61
Regular checks of blood pressure, heart rate, and other essential health indicators.
Vital Signs Monitoring
62
Periodic blood work and other diagnostic tests to assess organ function.
Laboratory Tests
63
Phase III CT
• Large Scale Testing • Comparative Studies • Long-Term Studies • Regulatory Submission
64
Phase III Trial Design and Enrollment
• Protocol Development • Patient Recruitment • Randomization • Treatment Administration
65
Regulatory Approval Process for Phase III
• Pre-NDA Meeting • NDA Submission • FDA Review • Advisory Committee
66
Discussion with regulatory agency about submission requirements
Pre-NDA Meeting
67
Comprehensive application including all clinical and non-clinical data.
NDA Submission
68
Thorough evaluation of submitted data by expert panels.
FDA Review
69
Public meeting to discuss benefits and risks of the new treatment.
Advisory Committee
70
It is a systematic process of evaluating the clinical trial operations at the site. It ensures that the clinical trial process is conducted according to the protocol, and predefined quality system procedures, following GCP guidelines, and according to the requirements of regulatory authorities.
Audit
71
• Focuses on safety and feasibility of new drug candidates. • Preclinical to early clinical trials. • 30-day FDA review.
Investigational New Drug (IND) Application
72
• Comprehensive evaluation of efficacy and safety. • Late-stage clinical trials and manufacturing data. • 10-month comprehensive FDA review.
New Drug Application (NDA)
73
List of objectionable conditons/processes prepared by the FDA Investigator and submitted to the auditee at the end or the inspection
483
74
The auditors submit their identity proofs and notice of inspections to the clinical investigators and later document their observations
482
75
This document details the fact that the clinical trial is not initiated before 30 days of submitting the IND to the FDA for approval. The form confirms that the IRB complies with 21 CFR Part 56. The form details the agreement to follow regulatory requirements and names all the individuals who monitor the conduct and progress of the study and evaluate the safety of the clinical trial
1571
76
This form details the fact that the study is conducted after ethics approval ensures that the study is carried out according to protocol, informed consent, and IRB approval
1572
77
Strategies for Successful NDA Submission
• Effective Communication • Robust Data • Meticulous Planning • Regulatory Compliance
78
Phase IV Clinical Trials
• Safety Monitoring • Efficacy Studies • Population Impact • Cost Effectiveness

DDD (10 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions